{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T07:56:51Z","timestamp":1793779011844,"version":"4.6.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>There is limited data on the cellular pharmacokinetics (PK) of the nucleos(t)ide reverse transcriptase inhibitors (NRTIs) in adolescents with HIV (AWH). We examined the steady-state concentrations of the NRTIs anabolites in dried blood spots (DBS) and peripheral blood mononuclear cells (PBMCs) in AWH and those with tuberculosis (TB) confection on rifampin-containing TB treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>AWH and TB\/HIV coinfection on TB treatment receiving tenofovir (TFV) disoproxil fumarate (TDF) 300\u2009mg\/lamivudine (3TC) 300\u2009mg or emtricitabine (FTC) 200\u2009mg daily for at least 8 weeks were enrolled. DBS were collected at the study entry. Following 2 weeks of telephone adherence reminders, DBS sampling was repeated, and 4 PBMC samples were collected between 10 and 20 hours postdose. Concentrations of TFV diphosphate (TFV-DP), 3TC triphosphate and FTC triphosphate in DBS and PBMCs were measured. Adherence based on TFV-DP concentrations in DBS and the anabolites concentrations in DBS and PBMCs were compared by TB coinfection status, and \u226414 versus &gt;14 years old.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Of 52 participants (46.2% with TB), the median (interquartile range) age 15.0 (14.5\u201317.0) years, 25 (48.1%) were male. Adherence based on TFV-DP in DBS was not significantly different by TB coinfection status or age group. The concentrations of the anabolites in DBS and PBMCs were similar in AWH and TB\/HIV coinfection and \u226414 versus &gt;14 years of age; and median concentrations at the population level were similar to historical values in adults.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>The concentrations of the recommended NRTIs and pharmacokinetics-determined adherence were not significantly different in adolescents with TB or younger age.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000004831","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T17:00:38Z","timestamp":1744736438000},"page":"876-881","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Pharmacokinetics of Tenofovir Diphosphate, Lamivudine Triphosphate and Emtricitabine Triphosphate in Adolescents With HIV Infection With and Without Tuberculosis Coinfection"],"prefix":"10.1097","volume":"44","author":[{"given":"Sampson","family":"Antwi","sequence":"first","affiliation":[{"name":"Department of Child Health, School of Medical Sciences, Kwame Nkrumah University of Science and Technology"},{"name":"Directorate of Child Health, Komfo Anokye Teaching Hospital, Kumasi, Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Enimil","sequence":"additional","affiliation":[{"name":"Department of Child Health, School of Medical Sciences, Kwame Nkrumah University of Science and Technology"},{"name":"Directorate of Child Health, Komfo Anokye Teaching Hospital, Kumasi, Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Computational Biology, University of Rochester School of Medicine and Dentistry, Rochester, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Martyn-Dickens","sequence":"additional","affiliation":[{"name":"Directorate of Child Health, Komfo Anokye Teaching Hospital, Kumasi, Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Dompreh","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Komfo Anokye Teaching Hospital"},{"name":"Department of Medical Diagnostics, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikins Kofi","family":"Amissah","sequence":"additional","affiliation":[{"name":"Directorate of Child Health, Komfo Anokye Teaching Hospital, Kumasi, Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwayemisi","family":"Ojewale","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Florida College of Medicine, Gainesville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Bosomtwe","sequence":"additional","affiliation":[{"name":"Directorate of Child Health, Komfo Anokye Teaching Hospital, Kumasi, Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Sly-Moore","sequence":"additional","affiliation":[{"name":"Directorate of Child Health, Komfo Anokye Teaching Hospital, Kumasi, Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla","family":"Asiedu","sequence":"additional","affiliation":[{"name":"Directorate of Child Health, Komfo Anokye Teaching Hospital, Kumasi, Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augustina","family":"Frimpong Appiah","sequence":"additional","affiliation":[{"name":"Directorate of Child Health, Komfo Anokye Teaching Hospital, Kumasi, Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresah","family":"Opoku","sequence":"additional","affiliation":[{"name":"Directorate of Child Health, Komfo Anokye Teaching Hospital, Kumasi, Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ama D.","family":"Sarfo","sequence":"additional","affiliation":[{"name":"Directorate of Child Health, Komfo Anokye Teaching Hospital, Kumasi, Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lane R.","family":"Bushman","sequence":"additional","affiliation":[{"name":"Colorado Antiviral Pharmacology Laboratory and Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado-Anschutz Medical Campus, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Ellison","sequence":"additional","affiliation":[{"name":"Colorado Antiviral Pharmacology Laboratory and Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado-Anschutz Medical Campus, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael A.","family":"Alghamdi","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, College of Pharmacy, King Khalid University, Abha, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter L.","family":"Anderson","sequence":"additional","affiliation":[{"name":"Colorado Antiviral Pharmacology Laboratory and Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado-Anschutz Medical Campus, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1118-8331","authenticated-orcid":false,"given":"Awewura","family":"Kwara","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Florida College of Medicine, Gainesville, Florida"},{"name":"Medical Service, North Florida South Georgia Veterans Health System, Gainesville, Florida."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"key":"R2-20250819","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1097\/00002030-200310170-00003","article-title":"Antiviral dynamics and sex differences of zidovudine and lamivudine triphosphate concentrations in HIV-infected individuals.","volume":"17","author":"Anderson","year":"2003","journal-title":"AIDS"},{"key":"R3-20250819","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1097\/00002030-200009290-00010","article-title":"Zidovudine triphosphate and lamivudine triphosphate concentration-response relationships in HIV-infected persons.","volume":"14","author":"Fletcher","year":"2000","journal-title":"AIDS"},{"key":"R4-20250819","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/00002030-199406000-00007","article-title":"Correlates of zidovudine phosphorylation with markers of HIV disease progression and drug toxicity.","volume":"8","author":"Stretcher","year":"1994","journal-title":"AIDS"},{"key":"R5-20250819","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.01710-17","article-title":"Intracellular tenofovir-diphosphate and emtricitabine-triphosphate in dried blood spots following directly observed therapy.","volume":"62","author":"Anderson","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"R6-20250819","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1093\/cid\/ciy708","article-title":"Tenofovir diphosphate in dried blood spots is strongly associated with viral suppression in individuals with human immunodeficiency virus infections.","volume":"68","author":"Castillo-Mancilla","year":"2019","journal-title":"Clin Infect Dis"},{"key":"R7-20250819","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1089\/aid.2012.0089","article-title":"Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure.","volume":"29","author":"Castillo-Mancilla","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R8-20250819","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/jac\/dky559","article-title":"Emtricitabine triphosphate in dried blood spots is a predictor of viral suppression in HIV infection and reflects short-term adherence to antiretroviral therapy.","volume":"74","author":"Frasca","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"R9-20250819","article-title":"HIV\/AIDS data: Global and regional trends - UNICEF data.","year":"2023"},{"key":"R10-20250819","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/QAD.0b013e32835a9a2d","article-title":"Age-related differences in plasma and intracellular tenofovir concentrations in HIV-1-infected children, adolescents and adults.","volume":"27","author":"Baheti","year":"2013","journal-title":"AIDS"},{"key":"R11-20250819","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.1128\/AAC.01017-16","article-title":"Emtricitabine-triphosphate in dried blood spots as a marker of recent dosing.","volume":"60","author":"Castillo-Mancilla","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"R12-20250819","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1089\/aid.2016.0008","article-title":"Intracellular tenofovir and emtricitabine anabolites in genital, rectal, and blood compartments from first dose to steady state.","volume":"32","author":"Seifert","year":"2016","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R13-20250819","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.","volume":"363","author":"Grant","year":"2010","journal-title":"N Engl J Med"},{"key":"R14-20250819","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1097\/QAD.0000000000003062","article-title":"Tenofovir-diphosphate in peripheral blood mononuclear cells during low, medium and high adherence to emtricitabine\/tenofovir alafenamide vs. emtricitabine\/tenofovir disoproxil fumarate.","volume":"35","author":"Yager","year":"2021","journal-title":"AIDS"},{"key":"R15-20250819","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/QAI.0000000000002354","article-title":"Intracellular tenofovir-diphosphate and emtricitabine-triphosphate in dried blood spots following tenofovir alafenamide: the TAF-DBS study.","volume":"84","author":"Yager","year":"2020","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R16-20250819","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jpba.2016.01.038","article-title":"Application of an intracellular assay for determination of tenofovir-diphosphate and emtricitabine-triphosphate from erythrocytes using dried blood spots.","volume":"122","author":"Zheng","year":"2016","journal-title":"J Pharm Biomed Anal"},{"key":"R17-20250819","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/jac\/dkaa070","article-title":"Factors associated with tenofovir diphosphate concentrations in dried blood spots in persons living with HIV.","volume":"75","author":"Coyle","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"R18-20250819","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/cid\/ciab1068","article-title":"Use of tenofovir diphosphate levels to predict viremia during the postpartum period in women living with human immunodeficiency virus (HIV): a nested case-control study.","volume":"75","author":"Odayar","year":"2022","journal-title":"Clin Infect Dis"},{"key":"R19-20250819","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1177\/135965350501000308","article-title":"Lack of a metabolic and antiviral drug interaction between tenofovir, abacavir and lamivudine.","volume":"10","author":"Ray","year":"2005","journal-title":"Antivir Ther"},{"key":"R20-20250819","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1128\/AAC.42.3.612","article-title":"Anti-human immunodeficiency virus activity and cellular metabolism of a potential prodrug of the acyclic nucleoside phosphonate 9-R-(2-phosphonomethoxypropyl)adenine (PMPA), Bis(isopropyloxymethylcarbonyl)PMPA.","volume":"42","author":"Robbins","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"R21-20250819","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1089\/aid.2004.20.1173","article-title":"Pharmacokinetic and pharmacodynamic characteristics of emtricitabine support its once daily dosing for the treatment of HIV infection.","volume":"20","author":"Wang","year":"2004","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R22-20250819","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/QAD.0000000000003818","article-title":"Urine tenofovir and dried blood spot tenofovir diphosphate concentrations and viraemia in people taking efavirenz and dolutegravir-based antiretroviral therapy.","volume":"38","author":"Dorward","year":"2024","journal-title":"AIDS"},{"key":"R23-20250819","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/QAI.0000000000003341","article-title":"Relationship between tenofovir diphosphate concentrations in dried blood spots and virological outcomes after initiating tenofovir-lamivudine-dolutegravir as first-line or second-line antiretroviral therapy.","volume":"95","author":"van Heerden","year":"2024","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R24-20250819","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-133-1-200007040-00004","article-title":"Adherence to protease inhibitor therapy and outcomes in patients with HIV infection.","volume":"133","author":"Paterson","year":"2000","journal-title":"Ann Intern Med"},{"key":"R25-20250819","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1016\/S2352-3018(21)00300-3","article-title":"A 4-days-on and 3-days-off maintenance treatment strategy for adults with HIV-1 (ANRS 170 QUATUOR): a randomised, open-label, multicentre, parallel, non-inferiority trial.","volume":"9","author":"Landman","year":"2022","journal-title":"Lancet HIV"},{"key":"R26-20250819","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3390\/jpm13040583","article-title":"Intermittent bictegravir\/emtricitabine\/tenofovir alafenamide treatment maintains high level of viral suppression in virally suppressed people living with HIV.","volume":"13","author":"Sellem","year":"2023","journal-title":"J Pers Med"},{"key":"R27-20250819","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1128\/AAC.49.2.680-684.2005","article-title":"Pharmacokinetic study of tenofovir disoproxil fumarate combined with rifampin in healthy volunteers.","volume":"49","author":"Droste","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"R28-20250819","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1093\/jac\/dkz068","article-title":"Rifampicin effect on intracellular and plasma pharmacokinetics of tenofovir alafenamide.","volume":"74","author":"Cerrone","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"R29-20250819","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/jac\/dkq447","article-title":"Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection.","volume":"66","author":"Anderson","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"R30-20250819","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1128\/AAC.01064-08","article-title":"Pilot pharmacokinetic study of human immunodeficiency virus-infected patients receiving tenofovir disoproxil fumarate (TDF): investigation of systemic and intracellular interactions between TDF and abacavir, lamivudine, or lopinavir-ritonavir.","volume":"53","author":"Pruvost","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R31-20250819","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1128\/AAC.06337-11","article-title":"Effect of HIV-1 infection and sex on the cellular pharmacology of the antiretroviral drugs zidovudine and lamivudine.","volume":"56","author":"Rower","year":"2012","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004831","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T15:05:33Z","timestamp":1755615933000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004831","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,10]]}}}